H J Guchelaar Selected Research

H J Guchelaar Research Topics

Disease

12	Neoplasms (Cancer) 01/2018 - 08/2000
7	Breast Neoplasms (Breast Cancer) 06/2023 - 12/2012
4	Melanoma (Melanoma, Malignant) 11/2009 - 12/2000
3	Neoplasm Metastasis (Metastasis) 10/2020 - 12/2000
3	Colorectal Neoplasms (Colorectal Cancer) 01/2017 - 02/2014
3	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 03/2005 - 10/2001
2	Renal Insufficiency (Renal Failure) 01/2018 - 06/2014
2	Thyroid Neoplasms (Thyroid Cancer) 07/2016 - 01/2015
1	Chronic Renal Insufficiency 01/2018
1	Gastrointestinal Stromal Tumors (Gastrointestinal Stromal Tumor) 01/2018
1	Renal Cell Carcinoma (Grawitz Tumor) 01/2017
1	Stomatitis 07/2016
1	Neuroendocrine Tumors (Neuroendocrine Tumor) 01/2015
1	Febrile Neutropenia 01/2015
1	Adrenocortical Carcinoma 12/2014
1	Osteosarcoma (Osteogenic Sarcoma) 06/2014
1	Liver Diseases (Liver Disease) 02/2014
1	Heart Diseases (Heart Disease) 08/2013
1	Hot Flashes 12/2012
1	Myositis (Idiopathic Inflammatory Myopathies) 08/2010
1	Muscular Diseases (Myopathy) 08/2010
1	Myalgia 08/2010
1	Cardiovascular Diseases (Cardiovascular Disease) 08/2010
1	Skin Neoplasms (Skin Cancer) 11/2009
1	Juvenile Arthritis (Juvenile Idiopathic Arthritis) 01/2009
1	Neuroblastoma 08/2007
1	Motor Neuron Disease (Primary Lateral Sclerosis) 03/2005
1	Necrosis 12/2001
1	Liposarcoma 12/2000
1	Sarcoma (Soft Tissue Sarcoma) 12/2000
1	Hyperthermia 12/2000
1	HIV Infections (HIV Infection) 09/2000
1	Thrombocytopenia (Thrombopenia) 09/2000
1	Cryptococcosis 08/2000
1	Mycoses (Diseases, Fungus) 08/2000
1	Aspergillosis 08/2000
1	Chromoblastomycosis (Chromomycosis) 08/2000

Drug/Important Bio-Agent (IBA)

6	Tamoxifen FDA LinkGeneric 06/2023 - 12/2012
3	Biomarkers (Surrogate Marker)IBA 10/2020 - 01/2015
3	Everolimus FDA Link 01/2018 - 01/2015
3	Sunitinib (Sutent)FDA Link 01/2018 - 01/2014
3	Riluzole FDA LinkGeneric 03/2005 - 10/2001
2	Cytochrome P-450 CYP2D6 (CYP2D6)IBA 11/2021 - 04/2015
2	Panitumumab (Vectibix)FDA Link 01/2018 - 02/2014
2	Docetaxel (Taxotere)FDA Link 12/2015 - 01/2015
2	Cetuximab (Erbitux)FDA Link 12/2015 - 06/2014
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 08/2010 - 11/2007
1	Cytochrome P-450 CYP2C19IBA 11/2021
1	Mitomycin (Mitomycin-C)FDA LinkGeneric 10/2020
1	SU 12662IBA 01/2017
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2017
1	Tyrosine Kinase InhibitorsIBA 01/2017
1	Fluorouracil (Carac)FDA LinkGeneric 11/2016
1	ProdrugsIBA 11/2016
1	Capecitabine (Xeloda)FDA Link 11/2016
1	Taxoids (Taxanes)IBA 12/2015
1	Simvastatin (Zocor)FDA LinkGeneric 12/2015
1	Paclitaxel (Taxol)FDA LinkGeneric 12/2015
1	taxaneIBA 12/2015
1	Dextromethorphan (Racemethorphan)FDA LinkGeneric 04/2015
1	AnthracyclinesIBA 01/2015
1	ParaffinIBA 01/2015
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2015
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2015
1	DNA (Deoxyribonucleic Acid)IBA 01/2015
1	Formaldehyde (Formol)FDA Link 01/2015
1	Mitotane (Lysodren)FDA Link 12/2014
1	Midazolam (Versed)FDA LinkGeneric 01/2014
1	Cardiac GlycosidesIBA 08/2013
1	exemestane (Aromasin)FDA Link 12/2012
1	EnzymesIBA 08/2010
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2009
1	Angiotensin Receptor AntagonistsIBA 11/2009
1	Estrogens (Estrogen)FDA Link 02/2009
1	Oral ContraceptivesIBA 02/2009
1	Methotrexate (Mexate)FDA LinkGeneric 01/2009
1	Antirheumatic Agents (DMARD)IBA 01/2009
1	CTP synthetaseIBA 08/2007
1	Antiviral Agents (Antivirals)IBA 08/2007
1	Cytarabine (Cytosar-U)FDA LinkGeneric 08/2007
1	Gemcitabine FDA Link 08/2007
1	Cytochrome P-450 CYP1A2 (CYP1A2)IBA 03/2005
1	Interleukin-6 (Interleukin 6)IBA 12/2001
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 12/2001
1	Erythromycin (Erycette)FDA LinkGeneric 12/2001
1	Carboplatin (JM8)FDA LinkGeneric 12/2000
1	CreatinineIBA 09/2000
1	Flucytosine (Ancobon)FDA Link 09/2000
1	Thalidomide (Thalomid)FDA Link 09/2000
1	Antifungal AgentsIBA 08/2000
1	Amphotericin B (Amphotericin)FDA LinkGeneric 08/2000
1	AzolesIBA 08/2000

Therapy/Procedure

9	Therapeutics 06/2019 - 09/2000
3	Drug Therapy (Chemotherapy) 01/2015 - 08/2007
1	Hyperthermic Intraperitoneal Chemotherapy 10/2020
1	Cytoreduction Surgical Procedures 10/2020
1	Drug Tapering 07/2016
1	Neoadjuvant Therapy 01/2015
1	Secondary Prevention 08/2010
1	Time-to-Treatment 01/2009